0000899243-21-002179.txt : 20210115
0000899243-21-002179.hdr.sgml : 20210115
20210115160508
ACCESSION NUMBER: 0000899243-21-002179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210113
FILED AS OF DATE: 20210115
DATE AS OF CHANGE: 20210115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sinha Uma
CENTRAL INDEX KEY: 0001742587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38533
FILM NUMBER: 21532135
MAIL ADDRESS:
STREET 1: C/O EIDOS THERAPEUTICS, INC.
STREET 2: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eidos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001731831
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463733671
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-391-9740
MAIL ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-13
0
0001731831
Eidos Therapeutics, Inc.
EIDX
0001742587
Sinha Uma
C/O EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, SUITE 2000
SAN FRANCISCO
CA
94104
1
1
0
0
Chief Scientific Officer
Common Stock
2021-01-13
4
S
0
696
121.1094
D
315829
D
Common Stock
2021-01-13
4
S
0
572
122.2667
D
315257
D
Common Stock
2021-01-13
4
S
0
1498
123.4787
D
313759
D
Common Stock
2021-01-13
4
S
0
4934
124.7187
D
308825
D
Common Stock
2021-01-13
4
S
0
2000
125.35
D
306825
D
Common Stock
2021-01-13
4
S
0
300
126.39
D
306525
D
This transaction was effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on August 13, 2020.
Represents the weighted average sale price of the shares sold ranging from $120.81 to $121.33 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 7.
Represents the weighted average sale price of the shares sold ranging from $121.98 to $122.89 per share.
Represents the weighted average sale price of the shares sold ranging from $123.01 to $124.00 per share.
Represents the weighted average sale price of the shares sold ranging from $124.10 to $125.09 per share.
Represents the weighted average sale price of the shares sold ranging from $125.11 to $125.66 per share.
Represents the weighted average sale price of the shares sold ranging from $126.30 to $126.57 per share.
/s/ Franco Valle, Attorney-in-Fact
2021-01-14